Drug intelligence / Profile preview

GamaSTAN

Development stage: Unknown
Lead developer: Grifols
Modality: Recombinant Proteins and Enzymes
Administration: Intramuscular

Overview

GamaSTAN (immune globulin [human]) is a sterile, preservative-free solution of polyvalent human immune globulin (15-18% protein) developed by Grifols Therapeutics LLC for intramuscular administration. It is a plasma-derived biologic produced through cold ethanol fractionation of pooled human plasma, containing a minimum of 20 IU/ml of anti-HAV antibodies. The drug provides passive immunization by transferring pre-formed antibodies to the recipient, offering immediate but temporary protection. It is the only FDA-approved immune globulin product for hepatitis A virus (HAV) prophylaxis and is also indicated for the prevention or modification of measles, varicella, and rubella in exposed, susceptible individuals.

Brand names: GamaSTANGamaSTAN S/D
Other names: Immune Globulin (Human)Polyvalent human immune globulin

Targets

MV (Measles virus)VZV glycoproteins (Varicella-zoster virus glycoproteins)Rubella virus surface glycoproteins (E1 and E2)Hepatitis A virus capsid protein

Beyond the preview

Go deeper on GamaSTAN.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GamaSTAN.

Explore the full profile